Related Experiment Videos

[Effectiveness of hemodynamic treatment guided by gastric intramucosal pH monitoring]

C Calvo Rey1, F Ruza Tarrío, M A Delgado Domínguez

  • 1Unidad de Cuidados Intensivos, Hospital Infantil La Paz.

Insights

Gastric intramucosal pH monitoring in critically ill children helps guide treatment. Normalizing this pH indicator is linked to fewer hemodynamic complications, improving patient outcomes.

Area of Science:

  • Pediatric Critical Care Medicine
  • Gastroenterology
  • Hemodynamics

Background:

  • Critically ill children often experience hemodynamic instability.
  • Monitoring tissue oxygenation is crucial for managing these patients.
  • Gastric intramucosal pH (pHi) is a potential indicator of tissue perfusion.

Purpose of the Study:

  • To evaluate gastric intramucosal pH as a marker for guiding hemodynamic treatment in critically ill children.
  • To assess the correlation between pHi normalization and the incidence of hemodynamic complications.

Main Methods:

  • A hemodynamic treatment protocol was applied to 34 critically ill children.
  • Gastric intramucosal pH was monitored, with normalization as the treatment endpoint.
  • Hemodynamic complications were compared between the treatment group and a control group receiving conventional care.

Main Results:

  • Treatment aimed at improving tissue oxygenation increased pHi values significantly (p = 0.014).
  • Children with a pHi < 7.30 showed a high incidence of hemodynamic complications (73%).
  • The control group with pHi < 7.30 had an even higher complication rate (93.8%).

Conclusions:

  • Gastric intramucosal pH is a valuable indicator for optimizing hemodynamic treatment in critically ill children.
  • Monitoring and normalizing pHi may help reduce the risk of hemodynamic complications.
Abstract

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...